Description
Description: Daruvir is a pharmaceutical product manufactured by Cipla Ltd. It contains Darunavir as its active substance and is primarily used in the treatment of HIV/AIDS. Daruvir is available in tablet form, with each tablet containing 300 mg of Darunavir. It is commonly packaged in a pack containing 60 tablets.
Active Substance: Darunavir is a protease inhibitor antiretroviral medication used in the treatment of HIV-1 infection in adults and children aged 3 years and older. It works by inhibiting the activity of the HIV protease enzyme, which is essential for viral replication. By blocking protease activity, Darunavir prevents the formation of mature viral particles, thereby reducing viral load and slowing the progression of HIV infection.
Manufacturer: Daruvir tablets are manufactured by Cipla Ltd, a reputable pharmaceutical company known for its commitment to producing high-quality medications. Cipla Ltd adheres to stringent manufacturing standards to ensure the safety, efficacy, and consistency of its products.
Strength and Formulation: Each tablet of Daruvir contains 300 mg of Darunavir as the active ingredient. The tablets are formulated for oral administration, making them convenient for patients to take as part of their antiretroviral therapy regimen.
Indications: Daruvir (Darunavir) is indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 3 years and older. It is used in combination with other antiretroviral agents as part of a comprehensive antiretroviral therapy regimen. Daruvir is not a cure for HIV infection but helps to suppress viral replication, improve immune function, and reduce the risk of disease progression and transmission to others.
Usage and Dosage: The dosage of Daruvir (Darunavir) may vary depending on factors such as the patient’s age, weight, renal function, and previous treatment history. It is usually taken orally once or twice daily, with or without food. The tablets should be swallowed whole with water and should not be crushed, chewed, or divided.
Storage Conditions: Daruvir tablets should be stored according to the manufacturer’s instructions, typically in a cool, dry place, away from direct sunlight, and at room temperature. They should be kept out of reach of children and pets to prevent accidental ingestion. Proper storage helps maintain the stability and efficacy of the medication.
Patients should consult their healthcare provider for personalized information regarding the use of Daruvir tablets, including dosage adjustments, potential side effects, and monitoring during treatment. Regular follow-up appointments are essential to evaluate treatment response and manage any adverse reactions.
Reviews
There are no reviews yet.